<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04395781</url>
  </required_header>
  <id_info>
    <org_study_id>2020/2094</org_study_id>
    <nct_id>NCT04395781</nct_id>
  </id_info>
  <brief_title>Pediatric Acute and Critical Care COVID-19 Registry of Asia</brief_title>
  <acronym>PACCOVRA</acronym>
  <official_title>Pediatric Acute and Critical Care COVID-19 Registry of Asia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KK Women's and Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King Chulalongkorn Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ramathibodi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Postgraduate Institute of Medical Education and Research, Chandigarh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rumah Sakit Anak dan Bunda Harapan Kita</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Marianna University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tokyo Metropolitan Children's Medical Center, Japan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aichi Children's Health and Medical Center, Japan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General Hospital H. Adam Malik</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhengzhou Children's Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universiti Kebangsaan Malaysia Medical Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Penang Hospital, Malaysia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vicente Sotto Memorial Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hyogo Prefectural Kobe Childrenâ€™s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Singapore Clinical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>KK Women's and Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In December 2019, an outbreak of pneumonia of unknown aetiology was first reported in the
      city of Wuhan, Hubei Province, People's Republic of China. Since then, a novel coronavirus,
      2019 novel Coronavirus (2019-nCoV) has emerged as the most likely causative agent. To date,
      it has evolved into a pandemic involving over a million cases and thousands of deaths have
      been identified, including a high burden in countries like Italy, Spain, United Kingdom and
      the United States. This study aims to investigate the clinical epidemiology of 2019-novel
      coronavirus (2019-nCoV) pandemic in Asia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A retrospective/prospective outbreak study of all suspect cases admitted to hospital since
      the beginning of the pandemic (December 2019). Clinical and epidemiological information will
      be extracted from medical databases for analysis.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 18, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>60 Days</target_duration>
  <primary_outcome>
    <measure>Overall severity of illness</measure>
    <time_frame>60days (or duration of hospital stay)</time_frame>
    <description>Mild, moderate, severe, critical</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory complications</measure>
    <time_frame>60days (or duration of hospital stay)</time_frame>
    <description>Respiratory diagnosis (e.g. URTI, pneumonia, ARDS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other complications</measure>
    <time_frame>60days (or duration of hospital stay)</time_frame>
    <description>Other systems involvement (e.g. SIRS, MODS, AKI, etc)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>60days (or duration of hospital stay)</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>COVID</condition>
  <condition>Pediatric Disorder</condition>
  <arm_group>
    <arm_group_label>Control cases</arm_group_label>
    <description>Children who suspected COVID-19 cases but tested negative for COVID-19</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Confirmed cases</arm_group_label>
    <description>Children who tested positive for COVID-19</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood Respiratory fluid Stool
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All children presenting to acute care hospitals within the PACCMAN collaborative sites.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COVID-19 suspected cases (by whatever definition)

          -  COVID-19 confirmed cases (based on PCR or serum specific IgM and IgG antibody of novel
             coronavirus; serum specific IgG of novel coronavirus from negative to positive or 4
             times higher in convalescence than in acute phase)

          -  &lt;/=21years of age

        Exclusion Criteria:

          -  COVID-19 suspected cases should not be SARSCoV-2, Influenza or RSV positive
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Judith Ju Ming Wong</last_name>
    <role>Principal Investigator</role>
    <affiliation>KK Women's and Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Judith Ju Ming Wong</last_name>
    <phone>+6592355980</phone>
    <email>judith.wong.jm@singhealth.com.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cecilia Chandra</last_name>
    <phone>63941616</phone>
    <email>cecilia.a.chandra@kkh.com.sg</email>
  </overall_contact_backup>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 18, 2020</study_first_submitted>
  <study_first_submitted_qc>May 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2020</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

